These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6367803)

  • 1. Development of 'auto-anti-A1 antibodies' following alloimmunization in an A2 recipient.
    Contreras M; Hazlehurst GR; Armitage SE
    Br J Haematol; 1983 Dec; 55(4):657-63. PubMed ID: 6367803
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of 'auto anti-A1 antibodies' following alloimmunization in an A2 recipient.
    Mangal AK; Sinclair M
    Br J Haematol; 1984 Aug; 57(4):714-6. PubMed ID: 6378249
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemolysis in ABO-incompatible liver transplantation.
    Angstadt J; Jarrell B; Maddrey W; Munoz S; Yang SL; Moritz M; Carabasi A
    Transplant Proc; 1987 Dec; 19(6):4595-7. PubMed ID: 3321627
    [No Abstract]   [Full Text] [Related]  

  • 4. Current experience with renal transplantation across the ABO barrier.
    Nelson PW; Helling TS; Shield CF; Beck M; Bryan CF
    Am J Surg; 1992 Nov; 164(5):541-4; discussion 544-5. PubMed ID: 1443385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch.
    De Santis GC; Garcia-Silva AC; Dotoli GM; de Castro PT; Simões BP; Covas DT
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28160319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of blood group A2 kidneys into O or B recipients: the effect of pretransplant anti-A titers on graft survival.
    Welsh KI; van Dam M; Koffman CG; Bewick ME; Rudge CJ; Taube DH; Clark AG
    Transplant Proc; 1987 Dec; 19(6):4565-7. PubMed ID: 3321621
    [No Abstract]   [Full Text] [Related]  

  • 7. The evaluation of graft irradiation as a method of preventing hemolysis after ABO-mismatched renal transplantation.
    Ishida H; Tanabe K; Tokumoto T; Shimmura H; Toma H
    Transpl Int; 2002 Sep; 15(8):421-4. PubMed ID: 12221462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High anti-A titres may not preclude ABO-incompatible renal transplantation: an autoantibody could be the culprit.
    Barnett N; Nightingale A; Maggs T; Needs M; Williams E; Curran D; Mamode N
    Nephrol Dial Transplant; 2010 Nov; 25(11):3794-6. PubMed ID: 20667991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of immunoadsorption and double filtration plasmapheresis for removal of anti-A or -B antibody in ABO-incompatible kidney transplantation. Japanese Biosynsorb Research Group.
    Agishi T; Takahashi K; Ota K; Yagisawa T
    Transplant Proc; 1992 Apr; 24(2):557-8. PubMed ID: 1566429
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies.
    Kumlien G; Ullström L; Losvall A; Persson LG; Tydén G
    Transfusion; 2006 Sep; 46(9):1568-75. PubMed ID: 16965585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolysis from ABO Incompatibility.
    Simmons DP; Savage WJ
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of immune anti-A and anti-B antibodies].
    Matveeva MA; Mineeva NV; Klimova KN; Volkova OIa
    Gematol Transfuziol; 1989 Oct; 34(10):42-4. PubMed ID: 2612855
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody to blood group glycosyltransferases in a patient transplanted with an ABO incompatible bone marrow.
    Kominato Y; Fujikura T; Takizawa H; Hayashi K; Mori T; Matsue K; Yasue S; Matsuda T
    Exp Clin Immunogenet; 1990; 7(2):85-90. PubMed ID: 2108709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.
    Fadeyi EA; Stratta RJ; Farney AC; Pomper GJ
    Am J Clin Pathol; 2014 May; 141(5):724-6. PubMed ID: 24713746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
    Sugiyama K; Hyodo Y; Aikawa A
    Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of hemolysis.
    Zipursky A
    Mead Johnson Symp Perinat Dev Med; 1982; (19):17-24. PubMed ID: 6821465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auto-anti-A1: another cause of ABO discrepancy.
    Rogers VB; Reid ME; Ellisor SS; Carrick S
    Transfusion; 1981; 21(1):92-5. PubMed ID: 7466913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of ABO A2 kidneys into O recipients: do IgM anti-A1 titers matter?
    Tierney J; Shaffer D
    Clin Transplant; 2015 Apr; 29(4):379-82. PubMed ID: 25659826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO-immunoglobulin G antibodies in intravenous immune globulin can interfere in ABO-mismatched kidney transplants.
    Boctor FN; Bhaskaran M; Sheahan B; Heaton WA; Molmenti E
    Transfusion; 2011 Aug; 51(8):1874-5. PubMed ID: 21831188
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterisation of the anti-A antibody response following an ABO incompatible (A2 to O) kidney transplantation.
    Rydberg L; Breimer ME; Holgersson J; Karlsson KA; Nyholm PG; Pascher I; Svensson L; Samuelsson BE
    Mol Immunol; 1992 Apr; 29(4):547-60. PubMed ID: 1373469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.